LCS
RNLX

Levin Capital Strategies’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Levin Capital Strategies’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-555,000
Closed -$117K – 281
2024
Q3 		$117K Hold
555,000
– – 0.01% 208
2024
Q2 		$128K Buy
+555,000
New +$331K 0.01% 209

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $762M AUM 23.02% 1-Year Est. Return

Levin Capital Strategies's RNLX Position: Q4 2024 in Review

Levin Capital Strategies sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 555,000 shares — an estimated $117K sold.

Levin Capital Strategies first reported a position in RNLX in Q2 2024 and held it in 2 quarters. The position peaked at $128K in Q2 2024. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Levin Capital Strategies reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Levin Capital Strategies sold 555,000 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $117K.
  • Levin Capital Strategies first reported a position in Renalytix plc American Depositary Shares in Q2 2024 and held it in 2 quarters.
  • Levin Capital Strategies's Renalytix plc American Depositary Shares position peaked at $128K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Levin Capital Strategies's 13F filing for Q4 2024, filed 5 Feb 2025.